SAN DIEGO, CA – February 10, 2015 – Pathway Genomics Corporation, a San Diego-based CLIA and CAP accredited clinical laboratory that offers genetic testing services globally, announced that Jacquelyn Powers, M.S., LCGC, of the Hospital of the University of Pennsylvania, and Ofri Leitner, M.S., CGC, of the University of North Carolina at Chapel Hill, have joined Pathway Genomics’ strategic advisory board. Powers and Leitner are well-respected clinical genetic counselors that are intimately involved in the hereditary cancer programs at their respective institutions.
President Obama announced the launch of a new Precision Medicine Initiative during his State of the Union address on January 20, 2015.
What does this mean for you and me?
SAN DIEGO, Calif., Jan. 23, 2015 – Pathway Genomics Corporation (“Pathway”) today announced a settlement agreement that ends the BRCA patent litigation against Pathway that began on June 13, 2014. Under the agreement, Myriad Genetics, Inc., the University of Utah Research Foundation, HSC Research and Development Limited Partnership, Endorecherche, Inc., and the Trustees of the University of Pennsylvania (the “Patent Owners”) and Pathway dismiss their respective claims and counterclaims against one another in the BRCA patent litigation. Additionally, the Patent Owners granted a covenant to not sue Pathway under the patents asserted in the litigation proceedings.
Pathway Genomics Adds The Honorable Dan Glickman, Former US Cabinet Member and Member of Congress, to Strategic Advisory Board
SAN DIEGO, CA – December 11, 2014 – Pathway Genomics Corporation, a San Diego-based CLIA and CAP accredited clinical laboratory that offers genetic testing services globally, announced that former U.S. Representative and Secretary of Agriculture Dan Glickman joined its strategic advisory board. “We’re honored to have Secretary Glickman as part of our advisory board,” said Jim Plante, Pathway Genomics’ founder and CEO. “In his 25 years in public service in Congress and as an advisor to the President as Cabinet Member, Dan Glickman distinguished himself as a solutions-oriented leader with impeccable integrity. His many accomplishments over that time speak for themselves, and we are extremely fortunate to now benefit from his vast experience.” Prior to his appointment as Secretary of Agriculture from 1995 until 2001, Glickman served for 18 years in the U.S. House of Representatives representing the 4th Congressional District of Kansas. During his tenure in the House, Glickman emphasized the roles of diet and nutrition in preventing diseases and promoting public health. In 2012 and 2013, Glickman chaired an Institute of Medicine Panel on “Accelerating Progress in Obesity Prevention.” “From a national perspective, I’ve been an advocate for increased prevention as it is clear by all measures that an ounce of prevention is worth a pound of cure,” said Glickman. “Genetics is the new frontier on prevention and Pathway is at the forefront of bringing this new information to physicians so that they can identify the best prevention program for a patient based on their overall risk factors.” Glickman served as Chairman of the Motion Picture Association of America, Inc. (MPAA) from 2004 until 2010, and is the Executive Director of the Aspen Institute Congressional Program, a nongovernmental, nonpartisan educational program for members of the United States Congress.
SAN DIEGO, CA – December 4, 2014 – Pathway Genomics Corporation, a San Diego-based CLIA and CAP accredited clinical laboratory that offers genetic testing services globally, announced that U.S. Congressman and Ambassador Tim Roemer has joined its strategic advisory board. A former U.S. ambassador to the Republic of India, Congressman Roemer holds a bachelor’s degree from the University of California San Diego, and masters and doctorate degrees in American government from the University of Notre Dame. “During his years of distinguished public service as a Member of Congress and as United States Ambassador to India, Tim Roemer worked tirelessly to improve the lives of people around the world. His success aligns perfectly with our mission at Pathway Genomics. Ambassador Roemer’s vast experience will be tremendously helpful to Pathway as we continue our rapid growth both here and abroad,” said Jim Plante, Pathway Genomics’ founder and CEO.